Tetramethoxyluteolin for the treatment of neurodegenerative diseases.

Conclusion Inhibition of inflammatory processes unique to the brain with intranasal formulations of tetramethoxyluteolin could provide new possibilities for the understanding and treatment of neurodegenerative diseases. PMID: 30451113 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30451113?dopt=Abstract

Source: Current Topics in Medicinal Chemistry - November 19, 2018 Category: Chemistry Authors: Theoharides TC, Tsilioni I Tags: Curr Top Med Chem Source Type: research